Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Med Mal News Image

Med Mal News

ALM Staff & Law Journal Newsletters

The latest news for your review.

Features

Drug & Device News Image

Drug & Device News

ALM Staff & Law Journal Newsletters

The latest happenings in this important area.

The Hospital Defendant Image

The Hospital Defendant

Elliott B. Oppenheim

Hospitals have a legal duty to make health care as safe as is possible so that the hospital, through practitioners under its aegis, can offer the proper standard of care. When the hospital fails in this regard, a lawyer may consider a negligent credentialing claim where the hospital did not appropriately credential a practitioner and a direct claim of negligence against the hospital where the institution did not have sufficient policies and procedures, and carry them out, in order to protect patients.

Features

Trends in Financial Services Patents Image

Trends in Financial Services Patents

Joel Lehrer

Armed with a well-stocked patent portfolio, a company can effectively corner valuable markets for a limited amount of time. While this concept is second nature for most makers of tangible products, pharmaceuticals, or even software, it is only now becoming widely accepted in the financial services sector. As a result, another battlefield is emerging in which patents are becoming the weapon of choice, and trading floors and back-office processing centers have become the new settings for patent disputes.

Features

Licensees May Challenge a Patent Without Breaching License: The Supreme Court's Decision in MedImmune, Inc. v. Genentech, Inc. Image

Licensees May Challenge a Patent Without Breaching License: The Supreme Court's Decision in MedImmune, Inc. v. Genentech, Inc.

Benjamin Hershkowitz & Scott Kolassa

'We hold that petitioner was not required, insofar as Article III is concerned, to break or terminate its 1997 license agreement before seeking a declaratory judgment in federal court that the underlying patent is invalid, unenforceable, or not infringed.'With this language, the U.S. Supreme Court concluded its 8-1 landmark decision in <i>MedImmune, Inc. v. Genentech, Inc.</i>, reversing the holding of the U.S. Court of Appeals for the Federal Circuit ('Federal Circuit'). This decision has potentially wide-ranging ramifications for patent licensing.

Features

Supreme Court Revisits Test for Deciding Obviousness Image

Supreme Court Revisits Test for Deciding Obviousness

Elizabeth Rader & Thomas Goldstein

The U.S. Supreme Court has recently shown an interest in intellectual property in general and patents in particular. Most prominent among the recent cases is <i>KSR International Co. v. Teleflex Inc.</i>, which presents perhaps the most difficult question in substantive patent law: When is the subject of a patent application a true 'invention' ' that is, something that promotes the progress of a useful art sufficient to warrant giving the applicant exclusive rights to the technology claimed for the next 20 years. Conversely, when is the invention 'obvious' ' merely taking a step that anyone of ordinary skill would take, confronted with the same problem and possessing all the knowledge already known to the field?

Drug Companies and Failure to Warn Image

Drug Companies and Failure to Warn

Tim O'Brien

For more than one year, product liability cases have been pending against Merck's osteoporosis drug, Fosamax'. Despite having one of the highest side effect profiles of any drug in the U.S. prescription database, Fosamax remains on the market, and available by prescription. When a drug remains on the market during litigation but the manufacturer refuses to warn about a known risk, places the information about the risk in an obscure location or provides inadequate information about the severity of the risk, there is a public problem ' for both patients and prescribers alike ' in the form of a health hazard about which most prescribers have insufficient information.

February issue in PDF format Image

February issue in PDF format

ALM Staff & Law Journal Newsletters

&#133;

Features

News Briefs Image

News Briefs

ALM Staff & Law Journal Newsletters

Highlights of the latest franchising news from around the country.

Med Mal Litigation Image

Med Mal Litigation

Kevin Quinley

Risk-managing one's medical practice involves gauging the quality of the legal advocacy put forth to advance a physician's professional interests. In medical malpractice litigation, as we all know, victory is fleeting but setbacks are long-lasting. Therefore, as an attorney, expect to be evaluated with an eagle eye ' and respond to your client's fears with professionalism and reassurance.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES